A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer
Clinical trial NCT07649928 · RECRUITING
Trial details
- NCT number
- NCT07649928
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-18
- Primary completion
- 2028-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.